Recapping The First Two Days Of ASHP Summer Meetings 2023

Article

What stood out on Sunday and Monday at the 2023 ASHP Summer Meetings in Baltimore?

Novel ADHD Therapy More Tolerable, Less Effective Than Current Treatment Options


Centanafadine is a serotonin-norepinephrine-dopamine triple reuptake inhibitor.

Read More

CGRP Inhibitors Significantly Reduce Disability in Migraine


Study results add to the body of evidence demonstrating the efficacy of CGRP inhibitors for migraine treatment and prophylaxis.


Read More

Why Are Pharmacogenomics Not Fully Implemented in Health Care?


A look at how the genetics-based research field can become more fully integrated in all areas of health care going forward.


Read More

Optimizing Oncology Drug Interaction Alerts to Improve Patient Safety


Although excessive use can lead to fatigue, alerts can help proactively identify and prevent drug interactions.


Read More

ASHP: Adalimumab Biosimilar Pipeline Review


At least 6 adalimumab biosimilars are set to launch in July 2023.

Read More


Related Videos
fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.